期刊文献+

肾移植术后环孢素血药浓度与患者体内因素相关性分析 被引量:4

Relevance of Blood Concentration of Cyclosporine A to In Vivo Factors of Patients After Undergoing Renal Transplantation
原文传递
导出
摘要 目的:研究肾移植术后环孢素(CsA)血药浓度与患者体内因素的相关性。方法:采用回顾性调查方法,查阅我院肾移植术后1周~1个月内服用CsA的患者病历,记录CsA血药浓度及相应的生化检验值,并应用SPSS13.0统计软件对数据进行全回归分析和多元线性回归分析。结果:全回归分析表明,在丙氨酸氨基转移酶(ALT)、天门冬酸氨基转移酶(AST)、AST/ALT、总蛋白(TP)、白蛋白(ALB)、直接胆红素(DBIL)、间接胆红素(IBIL)、胆碱酯酶(CHE)、总胆汁酸(TBA)、乳酸脱氢酶(LDH)、尿素(Urea)、尿酸(UA)、肌酐(Crea)等生化因素协同存在的情况下,上述各值与CsA单位剂量血药浓度存在线性关系(P<0.05);进一步用多元线性回归分析表明,CsA单位剂量血药浓度与TP之间存在线性关系(P<0.05)。结论:患者TP是影响CsA血药浓度的独立因素。而ALT、AST、AST/ALT、ALB、DBIL、IBIL、CHE、TBA、LDH、Urea、UA、Crea等可能与TP协同作用而影响CsA血药浓度。 OBJECTIVE: To study the relevance between blood concentration of cyclosporine A (CsA) and the in vivo factors of patients after undergoing renal transplantation. METHODS: Patients receiving oral CsA administration within 1wk-1mo after undergoing kidney transplantation in our hospital were reviewed retrospectively and the blood concentration of CsA and the corresponding biochemical testing values were recorded and analyzed with regression analysis and multiple linear regression analysis using SPSS 13.0 software. RESULTS: According to regression analysis, the linear statistical significance existed between the blood concentration of unit dose CsA and the corresponding biochemical values including ALT, AST, AST/ ALT, TP, ALB, DBIL, IBIL, CHE, TBA, LDH, Urea, UA and Crea(P〈0.05); And according to multiple linear regression analysis, the linear statistical significance existed between the blood concentration of unit dose CsA and the total protein (TP) (P 〈0.05). CONCLUSION: TP is the independent factor influencing the blood concentration of CsA. And the influence of the corresponding biochemical values such as ALT, AST, AST/ALT, ALB, DBIL, IBIL, CHE, TBA, LDH, Urea, UA, Crea on the blood concentration of CsA is possibly related to their joint action with TP.
出处 《中国药房》 CAS CSCD 北大核心 2008年第23期1795-1798,共4页 China Pharmacy
关键词 肾移植 环孢素 体内因素 相关性 Renal transplantation Cyclosporin A In vivo factors Relevance
  • 相关文献

参考文献3

二级参考文献8

  • 1倪根珊,药物临床应用撷萃,1994年,1097页
  • 2Hilbrans LB, Demacker PN, Hoitsma AJ, et al. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal tansplant recipients[J ] . J Am Soc Nephrol, 1995, 5(12) : 2 073.
  • 3Steinmuller TM, Graf KJ, Schleicher J, et al. The effect of FK506 versus cyclosporine on glucose and lipid metabolism- a randomized trial[J] . Transplantation,1994, 58(6) : 669.
  • 4张象麟.免疫系统药[A]..药物临床信息参考(第1版)[M].国家药品监督管理局药品审评中心、四川美康医药软件研究开发有限公司共同出版,2003.665-702.
  • 5傅祖植.血脂异常和脂蛋白异常血症[A].陈灏珠主编.内科学第6版[M].北京:人民卫生出版社,2004.821-831.
  • 6陈莲珍,王育琴.影响环孢菌素A血药浓度的因素和干预对策[J].中国药学杂志,2001,36(4):277-279. 被引量:17
  • 7周燕,储小曼.影响环孢素A血药浓度原因分析[J].中国医院药学杂志,2001,21(4):231-232. 被引量:20
  • 8葛卫红,丁义涛.肝移植受者术后早期CsA血药浓度波动特点及其影响因素分析[J].外科理论与实践,2002,7(2):159-160. 被引量:1

共引文献23

同被引文献38

  • 1高恒强,张书广,李庆敏.血清总胆汁酸测定在肝胆疾病中的诊断价值[J].山东医药,2005,45(22):22-22. 被引量:2
  • 2张春燕,顾健,杨薇,李玉珍.影响肝移植术后环孢素A血药浓度相关因素分析[J].中国药房,2006,17(1):39-41. 被引量:17
  • 3Beauchesne PR, Chung NS, Wasan KM. Cyclosporine A : a review of current oral and intravenous delivery systems [J]. Drug Dev lnd Pharm,2007,33( 3 ) :211.
  • 4Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metaboli- zing enzyme explains interactions of cyelosporine with other drugs [ J ]. Clin Pharmacol Ther, 1988,43 ( 6 ) :630.
  • 5Lown KS,Mayo RR,Leichtman AB,et al.Role of intesti-nal P-glycoprotein (mdrl) in interpatient variation in theoral bioavailability of cyclosporine[J]. Clin Pharmacol1997,62(3):248.
  • 6Ameyaw MM,Regateiro F,Li T,et, al.MDRl pharmaco-genetics :frequency of the C3435T mutation in exon 26 issignificantly influenced by ethnicity[J]. Pharmacogenetics,2001,11(3):217.
  • 7Wahlby U,Jonsson EN,Karlsson MO.Comparison of step-wise covariate model building strategies in population pha-nnacokinetic-pharmacodynamic analysis[J]. AAPS Pharm Sci,2002,4(4) :27.
  • 8Zhang Y,Benet LZ. The gut as a barrier to drug absorp-tion: combined role of cytochrome P4so 3A and P-glyco-protein[J]. Clin Pharmacokinet,2001: 159.
  • 9Hashida T, Masuda S,Uemoto S,et al.Pharmacokineticand prognostic significance of intestinal MDR1 expres-sion in recipients of living-donor liver transplantation[J].Clin Pharmacol Ther,2001,69(5) :308.
  • 10Hoffineyer S,Burk O, von Richter O,et al. Functionalpolymorphisms of the human multidrug-resistance gene:multiple sequence variations and correlation of one allelewith P-glycoprotein expression and activity in vivo[J].Proc Natl Acad Sci USA,2000,97(7) : 3 473.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部